Abstract
A nanoreservoir for efficient intracellular anticancer drug delivery based on mesoporous silica nanoparticles end-capped with lactobionic acid-grafted bovine serum albumin is fabricated. It demonstrates great potential for both cell-specific endocytosis and intracellular pH-responsive controlled release of drugs. A possible endocytosis pathway/mechanism of the smart controlled drug release system is proposed.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / chemistry
-
Delayed-Action Preparations / chemical synthesis*
-
Disaccharides / chemistry*
-
Doxorubicin / administration & dosage
-
Doxorubicin / chemistry*
-
Hep G2 Cells
-
Humans
-
Hydrogen-Ion Concentration
-
Materials Testing
-
Nanocapsules / chemistry*
-
Nanocapsules / ultrastructure
-
Particle Size
-
Porosity
-
Serum Albumin, Bovine / chemistry*
-
Silicon Dioxide / chemistry*
-
Subcellular Fractions / chemistry*
Substances
-
Antineoplastic Agents
-
Delayed-Action Preparations
-
Disaccharides
-
Nanocapsules
-
Serum Albumin, Bovine
-
lactobionic acid
-
Silicon Dioxide
-
Doxorubicin